Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for tat gene products (compound)
Most Correlated Studies
- T lymphocytes treated with HIV Tat protein
- CD4+ T cells expressing constitutively full-length or first-exon Tat protein of HIV-1
- Neuronal cortical cultures treated with HIV recombinant TAT (1–86), DDX3 inhibitor RK33 & cocaine
- Chronic myeloid leukemia RPMI8866 cells ectopically expressing HIV-1 mutant TAT C22G protein
Most Relevant Literature
- Role of HIV-1 Tat Protein Interactions with Host Receptors in HIV Infection and Pathogenesis.
- Features of Tat Protein in HIV-1 Sub-Subtype A6 Variants Circulating in the Moscow Region, Russia.
- HIV-1 Tat Protein-Mediated Inflammatory Response Inhibits the Erythroid Hematopoietic Support Functi…
- TAT-MeCP2 protein variants rescue disease phenotypes in human and mouse models of Rett syndrome.
- T-cell evasion and invasion during HIV-1 infection: The role of HIV-1 Tat protein.
Most Relevant Clinical Trials
- A Phase Il of a Therapeutic, Recombinant, Biologically Active HIV-1 Tat Protein Vaccine in HIV-Infec…
- Phase I Safety and Immunogenicity Preventative Vaccine Trial Based on Recombinant Tat Protein
- A Randomized Study of Activity, Safety, and Tolerance of Oral Ro 24-7429 (Tat Antagonist) in Patient…
- A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted E…
- A Gene Therapy Study for Hemophilia B
